Welker J, Pulido JD, Catanzaro AT, Malvestutto CD, et al. Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study. Lancet Infect Dis 2022 Mar 11. pii: S1473-3099(22)00058.
PMID: 35286843